# Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy

> **NCT00301600** · NA · COMPLETED · sponsor: **Nanjing University School of Medicine** · enrollment: 40 (actual)

## Conditions studied

- IGA Nephropathy

## Interventions

- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT00301600
- **Lead sponsor:** Nanjing University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2005-05
- **Final completion:** 2006-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301600, "Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00301600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*